OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Gabriella Miller Kids First Research Act

Floor Speech

Date: July 26, 2022
Location: Washington, DC

BREAK IN TRANSCRIPT

Mr. CARTER of Georgia. Mr. Speaker, I rise to express my support for H.R. 623, the Gabriella Miller Kids First Research Act 2.0.

This bill, which is supported by a large bipartisan group of cosponsors, including my Energy and Commerce Committee colleagues Bilirakis, Mullin, and McKinley, would reauthorize the Gabriella Miller Kids First Pediatric Cancer Research Initiative at the National Institutes of Health.

Cancer remains the leading cause of death from disease among children. According to the National Cancer Institute, an estimated 10,500 new cases of cancer will be diagnosed among children from birth to 14 years, and over 1,000 children are expected to die from the disease.

Children are not just little adults, and childhood cancer is not always treated like adult cancers. That is why it remains important to continue to support a robust pediatric oncology portfolio at the National Institutes of Health.

This legislation further prioritizes pediatric research and complements existing research activities of the National Institutes of Health.

Mr. Speaker, I am pleased to support this reauthorization honoring the courage and life of Gabriella Miller, and I urge a ``yes'' vote on this legislation.

BREAK IN TRANSCRIPT


Source
arrow_upward